Nvs Reddy
- All
- News
- Videos
-
Supreme Court Dismisses Andhra Pradesh Allegations Against Justice NV Ramana
The Andhra Pradesh government's complaint against Justice NV Ramana was dealt with according to the "in-house procedure" and stands dismissed, the Supreme Court said today, indicating that the matter was investigated internally by judges. Justice Ramana -- the most senior judge in the Supreme Court after the Chief Justice of India -- was named by J...
-
"Willful Disobedience": Attorney General On Jagan Reddy's Letter On Judge
Andhra Pradesh Chief Minister Jaganmohan Reddy's letter to Chief Justice of India SA Bobde - in which he complained about a Justice NV Ramana is, prima facie, a willful disobedience of authority, Attorney General KK Venugopal said Monday
-
Bhima-Koregaon Violence: 5th Judge Recuses From Hearing Activist Gautam Navlakha's Plea
Yet another Supreme Court judge today recused himself from hearing a plea filed by civil rights activist Gautam Navlakha against a Bombay High Court verdict refusing to scrap a police complaint lodged against him in the Bhima-Koregaon violence case.
-
Hyderabad Metro Rail To Be Extended To Yadadri Shrine: Managing Director
Hyderabad Metro Rail service would be extended to the famous hill shrine of Yadadri in Nalgonda district for the convenience of the devotees.
-
Dr Reddy's gets 93 per cent shares of OctoPlus
Dr Reddy's Laboratories (DRL), which is in the process of acquiring Netherlands-based specialty pharmaceutical company OctoPlus NV for about 27.4 million euro, has so far managed to get nearly 93 per cent shares of the firm in its favour.
-
Hyderabad Metro phase I to be completed by 2014: officials
Works related to Hyderabad Metro Rail are progressing at a brisk pace and phase-1 of the project will be completed by 2014 as per schedule despite the "challenges," officials said. "Year 2012 is a landmark for Hyderabad Metro Rail (HMR).
-
Dr Reddy's acquires 80 per cent shares in OctoPlus
Dr Reddy's Laboratories, which is in the process of acquiring Netherlands-based specialty pharmaceutical company OctoPlus NV for about 27.4 million euros, has so far managed to get nearly 80 per cent shares in its favour.
-
Supreme Court Dismisses Andhra Pradesh Allegations Against Justice NV Ramana
The Andhra Pradesh government's complaint against Justice NV Ramana was dealt with according to the "in-house procedure" and stands dismissed, the Supreme Court said today, indicating that the matter was investigated internally by judges. Justice Ramana -- the most senior judge in the Supreme Court after the Chief Justice of India -- was named by J...
-
"Willful Disobedience": Attorney General On Jagan Reddy's Letter On Judge
Andhra Pradesh Chief Minister Jaganmohan Reddy's letter to Chief Justice of India SA Bobde - in which he complained about a Justice NV Ramana is, prima facie, a willful disobedience of authority, Attorney General KK Venugopal said Monday
-
Bhima-Koregaon Violence: 5th Judge Recuses From Hearing Activist Gautam Navlakha's Plea
Yet another Supreme Court judge today recused himself from hearing a plea filed by civil rights activist Gautam Navlakha against a Bombay High Court verdict refusing to scrap a police complaint lodged against him in the Bhima-Koregaon violence case.
-
Hyderabad Metro Rail To Be Extended To Yadadri Shrine: Managing Director
Hyderabad Metro Rail service would be extended to the famous hill shrine of Yadadri in Nalgonda district for the convenience of the devotees.
-
Dr Reddy's gets 93 per cent shares of OctoPlus
Dr Reddy's Laboratories (DRL), which is in the process of acquiring Netherlands-based specialty pharmaceutical company OctoPlus NV for about 27.4 million euro, has so far managed to get nearly 93 per cent shares of the firm in its favour.
-
Hyderabad Metro phase I to be completed by 2014: officials
Works related to Hyderabad Metro Rail are progressing at a brisk pace and phase-1 of the project will be completed by 2014 as per schedule despite the "challenges," officials said. "Year 2012 is a landmark for Hyderabad Metro Rail (HMR).
-
Dr Reddy's acquires 80 per cent shares in OctoPlus
Dr Reddy's Laboratories, which is in the process of acquiring Netherlands-based specialty pharmaceutical company OctoPlus NV for about 27.4 million euros, has so far managed to get nearly 80 per cent shares in its favour.
